Literature DB >> 1440535

Inhibitory effect of activated protein C on platelet aggregation induced by the prothrombin-converting reaction.

K Komoriya1, K Inoue, K Takahashi, K Suzuki.   

Abstract

The present study was undertaken to elucidate the effect on platelet aggregation of the prothrombin-converting reaction on platelets with or without activated protein C (APC). A reaction mixture of washed platelets from human individuals, Factor Xa and prothrombin markedly induced platelet aggregation; maximum aggregation rates, 31.3-92.5%, and times to reach to maximum aggregation, 11.6 to 20.1 min. This aggregation was inhibited by the addition of APC with 50% inhibition concentration (IC50) value of 14.4 U/ml. APC also inhibited thrombin generation in the reaction mixture in a dose-dependent manner with IC50 value of 0.96 U/ml. However, APC did not inhibit the thrombin (0.1 CU/ml)-induced platelet aggregation at concentrations of up to 30 U/ml. These findings suggest that APC has no direct inhibitory effect on platelet aggregation and that APC inhibits platelet aggregation through inhibition of thrombin generation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1440535     DOI: 10.1016/0049-3848(92)90074-k

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  1 in total

1.  Esophagectomy for Esophageal Cancer in a Patient with Protein C Deficiency: A Case Report.

Authors:  Naoto Ujiie; Yusuke Taniyama; Hiroshi Okamoto; Chiaki Sato; Kai Takaya; Toshiaki Fukutomi; Takashi Kamei
Journal:  Ann Thorac Cardiovasc Surg       Date:  2020-08-19       Impact factor: 1.520

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.